Skip to main content

Table 2 GATA-6, GATA-4, and LHR expression in human adrenocortical tumors

From: Assessment of the role of transcript for GATA-4 as a marker of unfavorable outcome in human adrenocortical neoplasms

Patient Tumor Evolution GATA-6 Expression GATA-4 Expression LHR Expression
1 NM 2.43 1.09 0.54
2 NM 3.39 0.60 1.60
3 NM 3.58 1.75 1.60
4 NM 3.45 0.59 1.07
5 NM 3.21 0.05 1.64
6 NM 2.98 0.91 0.69
7 NM 2.59 0 0.83
8 NM 3.19 0.04 1.17
9 NM 2.62 0.70 1.00
10 NM 3.02 0.52 0.54
11 NM 3.45 0.14 3.84
12 NM 2.44 0.62 0.78
13 NM 3.11 0 1.57
14 MR 3.24 0.32 0.41
15 MR 2.30 3.50 0.44
16 MR 1.74 0.01 0.35
17 MR 2.81 2.50 0.41
18 MR 2.14 3.37 1.06
19 MR 2.61 2.17 0.33
20 MR 2.71 2.96 0.50
21 MR 2.83 0.12 0.48
22a MR 3.23 0.58 1.76
22b MR 2.07 2.23 1.83
  1. Patients are identified as in Table 1. Relative expression levels were calculated normalizing optical densities of GATA-6, GATA-4 and LHR autoradiograms with corresponding cyclophilin densitometric data as described in materials and methods. Samples 22a and 22b are tumor specimens removed from left (22a) and right (22b) adrenal of the same patient (patient 22, Table 1) NM: non-metastasizing, MR: metastasizing/recurring